Noa Bregman

Noa Bregman, MD, is a Senior Cognitive Neurologist and Director of the Cognitive Neurology Unit at Tel Aviv Sourasky Medical Center (Ichilov), Israel, and a Senior Lecturer at the Faculty of Medical and Health Sciences, Tel Aviv University. Her clinical and research work focuses on neurodegenerative diseases, particularly Alzheimer's disease, dementia with Lewy bodies, and genetic Creutzfeldt-Jakob disease (CJD). Dr. Bregman leads one of Israel's pioneering clinical programs for disease-modifying therapies in Alzheimer's disease, with extensive experience in the implementation, safety monitoring, and real-world outcomes of anti-amyloid treatments. Her research integrates advanced neuroimaging, fluid biomarkers, and clinical data to improve early diagnosis, patient selection, and treatment strategies. She also leads a longitudinal natural history study of presymptomatic carriers of genetic CJD, aiming to identify early biomarkers and support the development of preventive treatments. Dr.